Get the Daily Brief
Latest Biotech News
Advances in Spatial and Single-Cell Biology Drive Cancer Research
Collaborative initiatives like A*STAR’s TISHUMAP project and companies such as Stratica Biosciences and 10x Genomics are pioneering spatial transcriptomics and AI integration to analyze thousands...
Mitochondrial Donation and IVF Success in Preventing Genetic Diseases
A series of recent studies document successful births of children generated through three-person IVF techniques involving mitochondrial donation. These procedures transplant nuclear DNA from...
Med-Tech and Diagnostics Consolidation with Waters and BD Deal
Waters Corporation and Becton Dickinson (BD) announced a landmark $17.5 billion Reverse Morris Trust transaction, merging BD's Biosciences & Diagnostic Solutions business with Waters. The combined...
10x Genomics and A*STAR launch AI-driven spatial biology for drug discovery
10x Genomics and the A*STAR Genome Institute of Singapore have initiated the TISHUMAP project, leveraging 10x Genomics’ Xenium platform combined with advanced AI to analyze thousands of tissue...
Sarepta Therapeutics restructures amid Duchenne gene therapy safety concerns
Sarepta Therapeutics is executing a major strategic restructuring in response to safety issues linked to its Duchenne muscular dystrophy gene therapy Elevidys, following two patient deaths from...
Johnson & Johnson reports strong Q2 with med-tech growth offsetting Stelara decline
Johnson & Johnson exceeded analysts’ expectations in Q2 2025, driven by medical device sales reaching $8.54 billion and a remarkable 22.3% growth in cardiology. Innovative medicines revenue grew...
Bristol Myers and Pfizer roll out discounted direct-to-consumer Eliquis program
In a move to lower out-of-pocket costs for uninsured, underinsured, and self-pay patients ahead of Medicare price negotiations, Bristol Myers Squibb and Pfizer launched a direct-to-consumer...
Abbott’s Q2 diagnostics sales dip amid COVID testing decline and China policy impact
Abbott reported a 1% decline in its diagnostics segment sales to $2.17 billion in Q2 2025, impacted by a continued decrease in COVID-19 test volumes and China’s volume-based procurement program....
Newborn genome sequencing project in France seeks to revolutionize early diagnosis
The Perigenomed initiative in France is advancing routine genome sequencing-based newborn screening, aiming to transform early detection of hundreds of treatable rare diseases. The program has...
Nuclidium raises $98M to advance copper-based radiopharmaceuticals for cancer
Swiss-German radiopharmaceutical developer Nuclidium secured $98 million in Series B funding to propel clinical development and expand production of its copper-based radiotheranostics. The firm’s...
FDA raises safety concerns over GSK’s multiple myeloma antibody-drug conjugate Blenrep
Ahead of an advisory committee meeting, FDA reviewers highlighted significant safety issues with GSK’s Blenrep in multiple myeloma treatment, especially high rates of severe ocular toxicities...
Breakthroughs in spatial transcriptomics and AI fuel tumor microenvironment research
Researchers at Oregon Health & Science University have developed OmicsTweezer, an AI-powered model integrating single-cell and bulk omics data to enhance tumor tissue analysis. Leveraging deep...
FDA narrows Moderna Covid vaccine approval for children, underscoring regulatory fractures
FDA’s Center for Biologics Evaluation and Research director Vinay Prasad overruled unanimous agency reviewers to limit Moderna’s Spikevax COVID-19 vaccine full approval to children aged 6 months...
Sarepta Therapeutics Restructures After DMD Therapy Safety Issues
Sarepta Therapeutics has announced a significant restructuring following safety concerns tied to its Duchenne muscular dystrophy (DMD) gene therapy, Elevidys. The company plans to cut...
Global Neurodegeneration Proteomics Consortium Unveils Biomarkers
The Global Neurodegeneration Proteomics Consortium (GNPC) has released one of the largest proteomic datasets encompassing approximately 250 million protein measurements from over 35,000 biosamples...
Sino Biopharmaceutical Acquires LaNova Medicines for $951 Million
Sino Biopharmaceutical Ltd. has agreed to acquire nearly all remaining shares of LaNova Medicines Ltd., a Chinese biotech with a pipeline of eight clinical-stage candidates including antibody-drug...
FDA Raises Concerns Over GSK’s Multiple Myeloma Drug Blenrep
Ahead of an advisory committee meeting, the FDA has flagged significant safety concerns for GSK’s antibody-drug conjugate Blenrep (belantamab mafodotin), notably high rates of ocular toxicity...
Advances in AI and Single-Cell Technologies Propel Oncology and Diagnostics
Several companies and academic groups are harnessing AI and single-cell platforms to improve cancer diagnostics and drug discovery. One Biosciences, a French startup, raised €15 million to...
FDA Urges More Data for Otsuka's PTSD Treatment Rexulti
The FDA has challenged the efficacy data package for Otsuka Pharmaceutical’s Rexulti, an add-on therapy for post-traumatic stress disorder (PTSD), requesting additional studies ahead of an...
Merck Acquires Verona Pharma, Secures Long-Term IP on COPD Drug
Merck & Co.’s $10 billion acquisition of Verona Pharma secures rights to Ohtuvayre, a novel inhaled PDE3/4 inhibitor approved for chronic obstructive pulmonary disease (COPD). Despite the...